Description
A cyclic heptapeptide analog of α-MSH acting at central melanocortin receptors. Approved as Vyleesi® for hypoactive sexual desire disorder; widely studied in melanocortin pathway research.
A cyclic heptapeptide analog of α-MSH acting at central melanocortin receptors. Approved as Vyleesi® for hypoactive sexual desire disorder; widely studied in melanocortin pathway research.
A cyclic heptapeptide analog of α-MSH acting at central melanocortin receptors. Approved as Vyleesi® for hypoactive sexual desire disorder; widely studied in melanocortin pathway research.